Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Artery Disease | 209 | 2024 | 6569 | 14.340 |
Why?
|
Coronary Angiography | 157 | 2024 | 4541 | 13.280 |
Why?
|
Sarcoidosis | 29 | 2024 | 535 | 8.000 |
Why?
|
Myocardial Perfusion Imaging | 51 | 2024 | 672 | 6.660 |
Why?
|
Cardiomyopathies | 41 | 2024 | 2057 | 6.020 |
Why?
|
Myocardial Infarction | 63 | 2024 | 11521 | 5.760 |
Why?
|
Coronary Stenosis | 27 | 2024 | 802 | 5.580 |
Why?
|
Tomography, X-Ray Computed | 122 | 2023 | 20776 | 5.440 |
Why?
|
Chest Pain | 31 | 2023 | 1101 | 5.190 |
Why?
|
Cardiology | 28 | 2023 | 1701 | 4.730 |
Why?
|
Atherosclerosis | 53 | 2024 | 3431 | 4.480 |
Why?
|
Plaque, Atherosclerotic | 31 | 2024 | 1550 | 4.410 |
Why?
|
Predictive Value of Tests | 152 | 2024 | 15471 | 4.250 |
Why?
|
Coronary Vessels | 57 | 2024 | 3124 | 4.060 |
Why?
|
Fractional Flow Reserve, Myocardial | 23 | 2024 | 346 | 4.020 |
Why?
|
Lipoprotein(a) | 10 | 2024 | 490 | 3.680 |
Why?
|
Exercise Test | 26 | 2024 | 2187 | 3.460 |
Why?
|
Calcinosis | 25 | 2023 | 1479 | 3.430 |
Why?
|
Cardiovascular Diseases | 71 | 2024 | 15661 | 3.260 |
Why?
|
Cardiac Imaging Techniques | 16 | 2024 | 280 | 3.260 |
Why?
|
Positron-Emission Tomography | 63 | 2024 | 6673 | 3.170 |
Why?
|
Fluorodeoxyglucose F18 | 22 | 2022 | 2056 | 3.140 |
Why?
|
Myocarditis | 15 | 2024 | 803 | 3.030 |
Why?
|
Calcium | 46 | 2024 | 5792 | 2.990 |
Why?
|
Registries | 32 | 2024 | 8384 | 2.540 |
Why?
|
Coronary Circulation | 33 | 2024 | 1617 | 2.520 |
Why?
|
Myocardial Ischemia | 24 | 2023 | 2139 | 2.460 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 27 | 2024 | 1141 | 2.170 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 23 | 2024 | 3253 | 2.030 |
Why?
|
American Heart Association | 15 | 2024 | 1051 | 2.010 |
Why?
|
Heart Diseases | 17 | 2023 | 2819 | 1.900 |
Why?
|
Risk Assessment | 101 | 2024 | 24333 | 1.900 |
Why?
|
Humans | 536 | 2024 | 768970 | 1.900 |
Why?
|
Heart | 22 | 2023 | 4447 | 1.870 |
Why?
|
Magnetic Resonance Imaging, Cine | 21 | 2024 | 1092 | 1.830 |
Why?
|
Coronary Disease | 22 | 2023 | 5919 | 1.820 |
Why?
|
Risk Factors | 157 | 2024 | 74976 | 1.590 |
Why?
|
Ventricular Function, Left | 28 | 2024 | 3941 | 1.540 |
Why?
|
Prognosis | 86 | 2024 | 30046 | 1.440 |
Why?
|
Myocardium | 18 | 2024 | 4790 | 1.440 |
Why?
|
Aortic Valve Stenosis | 8 | 2023 | 2034 | 1.370 |
Why?
|
Middle Aged | 246 | 2024 | 223737 | 1.340 |
Why?
|
Diagnostic Imaging | 12 | 2023 | 3538 | 1.270 |
Why?
|
Male | 280 | 2024 | 365203 | 1.250 |
Why?
|
Radiology | 5 | 2022 | 2104 | 1.250 |
Why?
|
Hypolipidemic Agents | 5 | 2020 | 609 | 1.240 |
Why?
|
Mitral Valve | 8 | 2021 | 1475 | 1.240 |
Why?
|
Dyslipidemias | 9 | 2019 | 873 | 1.210 |
Why?
|
Coronary Vessel Anomalies | 3 | 2017 | 308 | 1.210 |
Why?
|
Female | 281 | 2024 | 397515 | 1.200 |
Why?
|
Cardiovascular System | 3 | 2020 | 841 | 1.180 |
Why?
|
Cholesterol, LDL | 10 | 2023 | 2403 | 1.160 |
Why?
|
Ventricular Outflow Obstruction | 2 | 2021 | 262 | 1.120 |
Why?
|
Endocarditis | 4 | 2020 | 352 | 1.120 |
Why?
|
Radiation Dosage | 12 | 2019 | 1970 | 1.090 |
Why?
|
Aortic Valve | 8 | 2023 | 1969 | 1.090 |
Why?
|
Heart Failure | 25 | 2024 | 11879 | 1.080 |
Why?
|
Echocardiography | 16 | 2023 | 5047 | 1.080 |
Why?
|
Electrocardiography | 28 | 2020 | 6413 | 1.050 |
Why?
|
Diabetes Mellitus | 17 | 2024 | 5892 | 1.040 |
Why?
|
Radiopharmaceuticals | 15 | 2022 | 2734 | 1.020 |
Why?
|
Hyperlipoproteinemia Type II | 3 | 2019 | 407 | 1.000 |
Why?
|
Heart Atria | 10 | 2021 | 1361 | 0.990 |
Why?
|
Heart Valve Prosthesis | 6 | 2021 | 1468 | 0.980 |
Why?
|
Out-of-Hospital Cardiac Arrest | 2 | 2019 | 340 | 0.940 |
Why?
|
Aged | 179 | 2024 | 171786 | 0.930 |
Why?
|
Stroke Volume | 26 | 2023 | 5622 | 0.920 |
Why?
|
Marijuana Abuse | 2 | 2018 | 409 | 0.910 |
Why?
|
Constriction, Pathologic | 12 | 2023 | 1104 | 0.880 |
Why?
|
Severity of Illness Index | 37 | 2024 | 15951 | 0.870 |
Why?
|
Diabetic Angiopathies | 3 | 2019 | 806 | 0.870 |
Why?
|
Heart Ventricles | 15 | 2023 | 3840 | 0.850 |
Why?
|
Retrospective Studies | 73 | 2024 | 81903 | 0.850 |
Why?
|
Tachycardia, Ventricular | 10 | 2024 | 1309 | 0.840 |
Why?
|
Contrast Media | 24 | 2024 | 5334 | 0.840 |
Why?
|
Troponin | 5 | 2023 | 535 | 0.820 |
Why?
|
Myocardial Revascularization | 7 | 2021 | 796 | 0.790 |
Why?
|
Adult | 119 | 2024 | 223851 | 0.780 |
Why?
|
Heart Injuries | 2 | 2021 | 207 | 0.780 |
Why?
|
Aortic Valve Insufficiency | 2 | 2016 | 577 | 0.770 |
Why?
|
Ammonia | 4 | 2023 | 248 | 0.760 |
Why?
|
Heart Valve Prosthesis Implantation | 5 | 2021 | 1568 | 0.760 |
Why?
|
Lifting | 1 | 2022 | 56 | 0.760 |
Why?
|
Image Enhancement | 5 | 2016 | 2898 | 0.760 |
Why?
|
Health Expenditures | 12 | 2020 | 2396 | 0.740 |
Why?
|
Cardiac-Gated Imaging Techniques | 6 | 2014 | 139 | 0.730 |
Why?
|
Practice Guidelines as Topic | 13 | 2021 | 7460 | 0.720 |
Why?
|
United States | 99 | 2024 | 73186 | 0.720 |
Why?
|
Consensus | 14 | 2022 | 3214 | 0.710 |
Why?
|
Carotid Artery Diseases | 5 | 2020 | 878 | 0.710 |
Why?
|
Coronavirus Infections | 8 | 2020 | 3118 | 0.700 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 2 | 2020 | 250 | 0.700 |
Why?
|
Heart Rate | 11 | 2024 | 4217 | 0.700 |
Why?
|
Pneumonia, Viral | 8 | 2020 | 3241 | 0.700 |
Why?
|
Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 33 | 0.690 |
Why?
|
Risk Reduction Behavior | 7 | 2020 | 1119 | 0.690 |
Why?
|
Vasodilator Agents | 10 | 2021 | 990 | 0.690 |
Why?
|
Preventive Health Services | 3 | 2020 | 570 | 0.690 |
Why?
|
Ventricular Dysfunction, Left | 10 | 2020 | 2145 | 0.680 |
Why?
|
Chi-Square Distribution | 17 | 2017 | 3438 | 0.680 |
Why?
|
Angina Pectoris | 6 | 2024 | 957 | 0.670 |
Why?
|
Gadolinium | 6 | 2022 | 965 | 0.670 |
Why?
|
Pandemics | 11 | 2021 | 8749 | 0.670 |
Why?
|
Death, Sudden, Cardiac | 9 | 2023 | 1568 | 0.670 |
Why?
|
Magnetic Resonance Imaging | 30 | 2022 | 36854 | 0.660 |
Why?
|
Diagnostic Techniques, Cardiovascular | 5 | 2021 | 153 | 0.660 |
Why?
|
Primary Prevention | 12 | 2021 | 1187 | 0.660 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 13 | 2024 | 1232 | 0.650 |
Why?
|
Acute Coronary Syndrome | 10 | 2023 | 2194 | 0.620 |
Why?
|
Time Factors | 49 | 2024 | 40261 | 0.620 |
Why?
|
Colchicine | 1 | 2020 | 257 | 0.620 |
Why?
|
Reproducibility of Results | 35 | 2024 | 20245 | 0.620 |
Why?
|
Cardiomyopathy, Hypertrophic | 3 | 2023 | 1335 | 0.610 |
Why?
|
Thoracic Surgical Procedures | 1 | 2022 | 350 | 0.610 |
Why?
|
Prevalence | 27 | 2024 | 15879 | 0.580 |
Why?
|
Follow-Up Studies | 40 | 2023 | 39394 | 0.580 |
Why?
|
Cardiovascular Agents | 4 | 2020 | 849 | 0.570 |
Why?
|
Heart Neoplasms | 2 | 2019 | 374 | 0.570 |
Why?
|
Recovery of Function | 3 | 2020 | 2990 | 0.570 |
Why?
|
Kidney Diseases | 4 | 2020 | 2100 | 0.560 |
Why?
|
Aortography | 2 | 2016 | 422 | 0.560 |
Why?
|
Ventricular Remodeling | 7 | 2022 | 1282 | 0.560 |
Why?
|
Amyloid Neuropathies, Familial | 1 | 2020 | 180 | 0.560 |
Why?
|
Patient Advocacy | 1 | 2019 | 362 | 0.560 |
Why?
|
Emergency Service, Hospital | 15 | 2023 | 7957 | 0.560 |
Why?
|
Arteritis | 1 | 2019 | 158 | 0.550 |
Why?
|
Incidence | 32 | 2024 | 21547 | 0.550 |
Why?
|
Natural Language Processing | 3 | 2024 | 1203 | 0.550 |
Why?
|
Eligibility Determination | 2 | 2017 | 421 | 0.540 |
Why?
|
Health Care Costs | 11 | 2021 | 3270 | 0.540 |
Why?
|
Catheter Ablation | 9 | 2024 | 2780 | 0.540 |
Why?
|
Nuclear Medicine | 7 | 2020 | 262 | 0.540 |
Why?
|
Cardiology Service, Hospital | 2 | 2020 | 242 | 0.530 |
Why?
|
Echocardiography, Stress | 2 | 2014 | 139 | 0.530 |
Why?
|
Psoriasis | 2 | 2021 | 926 | 0.530 |
Why?
|
Autoimmunity | 1 | 2024 | 1360 | 0.530 |
Why?
|
Heart Transplantation | 7 | 2021 | 3301 | 0.520 |
Why?
|
Mucormycosis | 1 | 2017 | 102 | 0.520 |
Why?
|
Radiology, Interventional | 1 | 2020 | 483 | 0.520 |
Why?
|
Appointments and Schedules | 1 | 2020 | 443 | 0.520 |
Why?
|
Coronary Artery Bypass | 7 | 2021 | 2194 | 0.510 |
Why?
|
Electrophysiologic Techniques, Cardiac | 2 | 2020 | 511 | 0.510 |
Why?
|
Sinus of Valsalva | 1 | 2016 | 60 | 0.500 |
Why?
|
Prosthesis Fitting | 1 | 2015 | 75 | 0.500 |
Why?
|
Triage | 4 | 2016 | 997 | 0.500 |
Why?
|
Young Adult | 36 | 2024 | 60131 | 0.500 |
Why?
|
Sensitivity and Specificity | 29 | 2023 | 14752 | 0.500 |
Why?
|
Treatment Outcome | 38 | 2024 | 65480 | 0.500 |
Why?
|
Biopsy | 10 | 2024 | 6805 | 0.490 |
Why?
|
Image Interpretation, Computer-Assisted | 7 | 2019 | 3411 | 0.490 |
Why?
|
Arrhythmias, Cardiac | 10 | 2023 | 2258 | 0.490 |
Why?
|
Aspergillosis | 1 | 2017 | 242 | 0.490 |
Why?
|
Renal Insufficiency, Chronic | 7 | 2024 | 2297 | 0.490 |
Why?
|
Heart Valve Diseases | 3 | 2014 | 1030 | 0.480 |
Why?
|
Thrombosis | 3 | 2018 | 2956 | 0.480 |
Why?
|
Hemodynamics | 4 | 2019 | 4199 | 0.480 |
Why?
|
Aortic Diseases | 3 | 2016 | 741 | 0.480 |
Why?
|
Syncope | 3 | 2018 | 430 | 0.470 |
Why?
|
Cocaine-Related Disorders | 1 | 2018 | 458 | 0.470 |
Why?
|
Ventricular Function | 1 | 2016 | 406 | 0.470 |
Why?
|
Tricuspid Atresia | 1 | 2014 | 37 | 0.470 |
Why?
|
Candidiasis | 1 | 2017 | 367 | 0.470 |
Why?
|
Anti-Inflammatory Agents | 2 | 2024 | 1811 | 0.470 |
Why?
|
Lipids | 5 | 2019 | 3345 | 0.460 |
Why?
|
Heart Murmurs | 1 | 2014 | 92 | 0.460 |
Why?
|
Tricuspid Valve | 2 | 2017 | 419 | 0.450 |
Why?
|
Fabry Disease | 1 | 2014 | 89 | 0.450 |
Why?
|
Health Resources | 3 | 2017 | 951 | 0.450 |
Why?
|
Quality Indicators, Health Care | 4 | 2020 | 1812 | 0.450 |
Why?
|
Societies, Medical | 14 | 2021 | 3968 | 0.440 |
Why?
|
Cause of Death | 12 | 2021 | 3721 | 0.440 |
Why?
|
Rubidium Radioisotopes | 4 | 2014 | 97 | 0.440 |
Why?
|
Abscess | 1 | 2017 | 606 | 0.430 |
Why?
|
Prospective Studies | 50 | 2024 | 54962 | 0.430 |
Why?
|
Cocaine | 1 | 2018 | 947 | 0.430 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2016 | 263 | 0.430 |
Why?
|
Central Nervous System Diseases | 1 | 2018 | 521 | 0.430 |
Why?
|
Pulmonary Valve | 1 | 2017 | 413 | 0.430 |
Why?
|
Asymptomatic Diseases | 7 | 2024 | 590 | 0.430 |
Why?
|
Adenosine | 4 | 2011 | 822 | 0.420 |
Why?
|
Subtraction Technique | 2 | 2013 | 519 | 0.420 |
Why?
|
Aortic Stenosis, Supravalvular | 1 | 2012 | 28 | 0.420 |
Why?
|
Radiography, Interventional | 1 | 2020 | 1131 | 0.420 |
Why?
|
Aneurysm, False | 2 | 2012 | 263 | 0.410 |
Why?
|
Embolism | 1 | 2016 | 401 | 0.410 |
Why?
|
Proportional Hazards Models | 18 | 2023 | 12562 | 0.400 |
Why?
|
Aged, 80 and over | 53 | 2024 | 59739 | 0.400 |
Why?
|
Microcirculation | 6 | 2023 | 1281 | 0.400 |
Why?
|
Cardiotonic Agents | 2 | 2014 | 544 | 0.400 |
Why?
|
Obesity | 17 | 2024 | 13091 | 0.400 |
Why?
|
Heart Aneurysm | 1 | 2012 | 114 | 0.390 |
Why?
|
Massachusetts | 8 | 2020 | 8894 | 0.380 |
Why?
|
Artificial Intelligence | 6 | 2024 | 2666 | 0.380 |
Why?
|
Decision Making | 2 | 2019 | 3953 | 0.380 |
Why?
|
Emergency Medical Services | 2 | 2014 | 1947 | 0.380 |
Why?
|
Inflammation | 14 | 2024 | 10868 | 0.380 |
Why?
|
Boston | 12 | 2019 | 9377 | 0.380 |
Why?
|
ROC Curve | 9 | 2024 | 3629 | 0.380 |
Why?
|
Acetanilides | 1 | 2013 | 169 | 0.380 |
Why?
|
Mass Screening | 3 | 2017 | 5457 | 0.380 |
Why?
|
Age Factors | 17 | 2024 | 18435 | 0.380 |
Why?
|
Disease Progression | 17 | 2024 | 13674 | 0.370 |
Why?
|
Information Dissemination | 1 | 2019 | 1141 | 0.370 |
Why?
|
Mitral Valve Insufficiency | 2 | 2018 | 1415 | 0.370 |
Why?
|
Aspirin | 6 | 2024 | 3135 | 0.370 |
Why?
|
Fasting | 2 | 2022 | 1610 | 0.370 |
Why?
|
North America | 4 | 2022 | 1290 | 0.360 |
Why?
|
Cost Savings | 7 | 2020 | 915 | 0.360 |
Why?
|
Angiocardiography | 1 | 2010 | 149 | 0.360 |
Why?
|
Hypertrophy, Left Ventricular | 4 | 2023 | 856 | 0.360 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2016 | 595 | 0.350 |
Why?
|
Systole | 5 | 2020 | 937 | 0.350 |
Why?
|
Evidence-Based Medicine | 5 | 2020 | 3709 | 0.350 |
Why?
|
Multivariate Analysis | 18 | 2017 | 12095 | 0.350 |
Why?
|
Edema, Cardiac | 1 | 2009 | 19 | 0.340 |
Why?
|
Artifacts | 3 | 2014 | 1942 | 0.340 |
Why?
|
Impotence, Vasculogenic | 2 | 2020 | 13 | 0.340 |
Why?
|
Family Health | 2 | 2014 | 1255 | 0.340 |
Why?
|
Odds Ratio | 14 | 2018 | 9684 | 0.340 |
Why?
|
Organometallic Compounds | 4 | 2019 | 648 | 0.330 |
Why?
|
Cohort Studies | 24 | 2024 | 41808 | 0.330 |
Why?
|
Hospital Costs | 3 | 2019 | 959 | 0.330 |
Why?
|
Coronary Aneurysm | 1 | 2012 | 234 | 0.330 |
Why?
|
Sex Factors | 12 | 2020 | 10633 | 0.330 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2012 | 477 | 0.330 |
Why?
|
Health Status Indicators | 1 | 2014 | 971 | 0.330 |
Why?
|
Education, Medical, Graduate | 3 | 2020 | 2422 | 0.320 |
Why?
|
Smoking Cessation | 2 | 2020 | 2085 | 0.320 |
Why?
|
Phospholipids | 2 | 2024 | 787 | 0.320 |
Why?
|
Echocardiography, Transesophageal | 6 | 2020 | 1096 | 0.320 |
Why?
|
General Practitioners | 1 | 2010 | 103 | 0.320 |
Why?
|
Hypertension | 9 | 2024 | 8617 | 0.320 |
Why?
|
Aorta | 2 | 2016 | 2046 | 0.310 |
Why?
|
Models, Cardiovascular | 4 | 2021 | 983 | 0.310 |
Why?
|
Ambulatory Care | 3 | 2019 | 2784 | 0.310 |
Why?
|
Mortality | 4 | 2021 | 2914 | 0.310 |
Why?
|
Survival Analysis | 9 | 2021 | 10115 | 0.310 |
Why?
|
Research Report | 2 | 2021 | 369 | 0.300 |
Why?
|
Heart Defects, Congenital | 3 | 2019 | 4712 | 0.300 |
Why?
|
Pulmonary Veins | 4 | 2014 | 758 | 0.300 |
Why?
|
Renal Circulation | 1 | 2008 | 291 | 0.300 |
Why?
|
Health Status | 5 | 2019 | 4095 | 0.300 |
Why?
|
Kidney Failure, Chronic | 2 | 2018 | 2493 | 0.300 |
Why?
|
Socioeconomic Factors | 8 | 2024 | 7861 | 0.300 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2009 | 125 | 0.300 |
Why?
|
Age of Onset | 3 | 2021 | 3346 | 0.300 |
Why?
|
Survival Rate | 12 | 2020 | 12873 | 0.290 |
Why?
|
Quality Improvement | 2 | 2020 | 3860 | 0.290 |
Why?
|
Biomedical Research | 2 | 2020 | 3463 | 0.290 |
Why?
|
Gadolinium DTPA | 8 | 2019 | 823 | 0.290 |
Why?
|
Algorithms | 10 | 2021 | 14201 | 0.290 |
Why?
|
Medically Uninsured | 4 | 2021 | 841 | 0.280 |
Why?
|
Preventive Medicine | 2 | 2019 | 246 | 0.280 |
Why?
|
Occupational Health | 4 | 2021 | 812 | 0.280 |
Why?
|
Renin-Angiotensin System | 2 | 2008 | 736 | 0.280 |
Why?
|
Angiography | 1 | 2012 | 1598 | 0.280 |
Why?
|
Heart Valves | 2 | 2018 | 284 | 0.270 |
Why?
|
Guideline Adherence | 5 | 2020 | 2241 | 0.270 |
Why?
|
Perfusion | 5 | 2023 | 1402 | 0.270 |
Why?
|
Diffusion of Innovation | 3 | 2020 | 732 | 0.270 |
Why?
|
Atrial Fibrillation | 8 | 2018 | 5176 | 0.260 |
Why?
|
Meglumine | 3 | 2019 | 144 | 0.260 |
Why?
|
Kidney | 5 | 2024 | 7058 | 0.260 |
Why?
|
Shock, Cardiogenic | 2 | 2022 | 711 | 0.260 |
Why?
|
Cicatrix | 3 | 2024 | 799 | 0.260 |
Why?
|
Purines | 3 | 2015 | 615 | 0.260 |
Why?
|
Forecasting | 3 | 2020 | 2945 | 0.260 |
Why?
|
Arthritis, Rheumatoid | 1 | 2021 | 3780 | 0.260 |
Why?
|
Internal Mammary-Coronary Artery Anastomosis | 1 | 2005 | 38 | 0.250 |
Why?
|
Kaplan-Meier Estimate | 10 | 2019 | 6547 | 0.250 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2021 | 4056 | 0.250 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2011 | 615 | 0.250 |
Why?
|
Automation | 2 | 2023 | 589 | 0.250 |
Why?
|
Patient Selection | 9 | 2019 | 4265 | 0.250 |
Why?
|
Patient-Centered Care | 3 | 2021 | 1447 | 0.250 |
Why?
|
Electrophysiology | 1 | 2008 | 1266 | 0.250 |
Why?
|
Drug Costs | 3 | 2018 | 1198 | 0.240 |
Why?
|
Troponin T | 5 | 2023 | 787 | 0.240 |
Why?
|
Policy Making | 2 | 2019 | 546 | 0.240 |
Why?
|
Fibrosis | 7 | 2023 | 2080 | 0.240 |
Why?
|
C-Reactive Protein | 7 | 2023 | 3859 | 0.230 |
Why?
|
Safety Management | 2 | 2020 | 765 | 0.230 |
Why?
|
Diagnosis, Differential | 9 | 2024 | 13021 | 0.230 |
Why?
|
Immunotherapy | 1 | 2020 | 4756 | 0.230 |
Why?
|
Blood Pressure | 8 | 2018 | 8544 | 0.220 |
Why?
|
Liver Cirrhosis | 1 | 2014 | 1962 | 0.220 |
Why?
|
Technetium Tc 99m Pyrophosphate | 2 | 2020 | 52 | 0.220 |
Why?
|
Long QT Syndrome | 1 | 2008 | 472 | 0.220 |
Why?
|
Influenza Vaccines | 2 | 2021 | 781 | 0.220 |
Why?
|
Cost-Benefit Analysis | 7 | 2020 | 5544 | 0.220 |
Why?
|
Stroke | 7 | 2023 | 9756 | 0.220 |
Why?
|
Linear Models | 9 | 2019 | 5891 | 0.210 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2023 | 42 | 0.210 |
Why?
|
Hospital Mortality | 6 | 2022 | 5369 | 0.210 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2020 | 12253 | 0.210 |
Why?
|
Healthcare Disparities | 6 | 2022 | 3421 | 0.210 |
Why?
|
Observer Variation | 8 | 2024 | 2623 | 0.210 |
Why?
|
Randomized Controlled Trials as Topic | 9 | 2023 | 10400 | 0.210 |
Why?
|
Cadmium | 2 | 2022 | 217 | 0.210 |
Why?
|
Systemic Vasculitis | 1 | 2023 | 37 | 0.200 |
Why?
|
Income | 3 | 2021 | 1879 | 0.200 |
Why?
|
Comorbidity | 7 | 2021 | 10592 | 0.200 |
Why?
|
Life Style | 4 | 2020 | 3931 | 0.200 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2023 | 3782 | 0.200 |
Why?
|
Magnetic Resonance Angiography | 3 | 2014 | 1434 | 0.200 |
Why?
|
Nervous System Diseases | 1 | 2013 | 1665 | 0.200 |
Why?
|
Piperazines | 1 | 2013 | 2553 | 0.200 |
Why?
|
Amyloidosis | 3 | 2020 | 879 | 0.200 |
Why?
|
Curriculum | 4 | 2020 | 3782 | 0.200 |
Why?
|
Tomography, Spiral Computed | 2 | 2016 | 274 | 0.190 |
Why?
|
Echocardiography, Doppler, Color | 3 | 2018 | 353 | 0.190 |
Why?
|
Myocardial Contraction | 2 | 2019 | 1526 | 0.190 |
Why?
|
Decision Support Techniques | 4 | 2017 | 2008 | 0.190 |
Why?
|
Tomography Scanners, X-Ray Computed | 2 | 2020 | 172 | 0.190 |
Why?
|
Awareness | 2 | 2019 | 653 | 0.190 |
Why?
|
Comparative Effectiveness Research | 2 | 2019 | 714 | 0.190 |
Why?
|
Imaging, Three-Dimensional | 3 | 2015 | 4076 | 0.190 |
Why?
|
Health Surveys | 7 | 2021 | 4055 | 0.190 |
Why?
|
Logistic Models | 11 | 2019 | 13318 | 0.180 |
Why?
|
Tellurium | 1 | 2020 | 23 | 0.180 |
Why?
|
Clinical Trials as Topic | 4 | 2021 | 8055 | 0.180 |
Why?
|
Brazil | 4 | 2020 | 1250 | 0.180 |
Why?
|
Hypercholesterolemia | 3 | 2023 | 1145 | 0.180 |
Why?
|
Heart Conduction System | 2 | 2021 | 1009 | 0.180 |
Why?
|
Length of Stay | 6 | 2022 | 6526 | 0.170 |
Why?
|
Recurrence | 5 | 2024 | 8513 | 0.170 |
Why?
|
Diet | 5 | 2021 | 8088 | 0.170 |
Why?
|
Mummies | 1 | 2019 | 10 | 0.170 |
Why?
|
Microvessels | 2 | 2015 | 586 | 0.170 |
Why?
|
Referral and Consultation | 2 | 2010 | 3628 | 0.170 |
Why?
|
Medicare | 3 | 2021 | 6888 | 0.170 |
Why?
|
Sarcoidosis, Pulmonary | 1 | 2020 | 45 | 0.170 |
Why?
|
Nutritional Sciences | 1 | 2021 | 148 | 0.170 |
Why?
|
Secondary Prevention | 2 | 2023 | 1476 | 0.170 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2021 | 241 | 0.170 |
Why?
|
Zinc | 2 | 2022 | 677 | 0.170 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2021 | 360 | 0.170 |
Why?
|
Area Under Curve | 3 | 2024 | 1645 | 0.170 |
Why?
|
Fee Schedules | 1 | 2019 | 87 | 0.170 |
Why?
|
Menu Planning | 1 | 2019 | 29 | 0.160 |
Why?
|
Clinical Competence | 4 | 2020 | 4860 | 0.160 |
Why?
|
Health Services Misuse | 1 | 2021 | 249 | 0.160 |
Why?
|
Smoking | 11 | 2021 | 9094 | 0.160 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2024 | 2763 | 0.160 |
Why?
|
Insurance, Health, Reimbursement | 2 | 2020 | 390 | 0.160 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2020 | 325 | 0.160 |
Why?
|
Body Mass Index | 12 | 2018 | 13055 | 0.160 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2020 | 193 | 0.160 |
Why?
|
Prospective Payment System | 1 | 2019 | 136 | 0.160 |
Why?
|
Pyrazoles | 3 | 2015 | 2029 | 0.160 |
Why?
|
Diagnostic Self Evaluation | 1 | 2020 | 227 | 0.160 |
Why?
|
Insurance, Health | 2 | 2021 | 2518 | 0.160 |
Why?
|
Journal Impact Factor | 1 | 2020 | 156 | 0.150 |
Why?
|
Diet Therapy | 1 | 2019 | 150 | 0.150 |
Why?
|
Heart Arrest | 2 | 2022 | 1515 | 0.150 |
Why?
|
Up-Regulation | 2 | 2024 | 4148 | 0.150 |
Why?
|
Breast Implants | 1 | 2022 | 414 | 0.150 |
Why?
|
Defibrillators, Implantable | 2 | 2018 | 1498 | 0.150 |
Why?
|
Receptors, Somatostatin | 1 | 2019 | 138 | 0.150 |
Why?
|
Penile Erection | 1 | 2018 | 101 | 0.150 |
Why?
|
Biomedical Technology | 1 | 2020 | 210 | 0.150 |
Why?
|
Oxidation-Reduction | 1 | 2024 | 2226 | 0.150 |
Why?
|
Hospitals | 3 | 2020 | 3904 | 0.150 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13594 | 0.150 |
Why?
|
Thoracic Neoplasms | 1 | 2020 | 269 | 0.150 |
Why?
|
Prosthesis Failure | 3 | 2022 | 1209 | 0.150 |
Why?
|
Florida | 3 | 2024 | 430 | 0.150 |
Why?
|
Congresses as Topic | 2 | 2020 | 812 | 0.150 |
Why?
|
Cholesterol | 4 | 2020 | 2913 | 0.150 |
Why?
|
Autopsy | 2 | 2018 | 1013 | 0.150 |
Why?
|
Fatal Outcome | 3 | 2017 | 1836 | 0.140 |
Why?
|
Financing, Personal | 1 | 2020 | 310 | 0.140 |
Why?
|
Funnel Chest | 1 | 2018 | 75 | 0.140 |
Why?
|
Prediabetic State | 1 | 2023 | 548 | 0.140 |
Why?
|
Longitudinal Studies | 10 | 2024 | 14794 | 0.140 |
Why?
|
Exercise | 6 | 2021 | 5954 | 0.140 |
Why?
|
Heart Failure, Diastolic | 1 | 2018 | 77 | 0.140 |
Why?
|
Fatty Liver | 2 | 2014 | 810 | 0.140 |
Why?
|
Inflammation Mediators | 2 | 2024 | 1890 | 0.140 |
Why?
|
Nonlinear Dynamics | 2 | 2017 | 494 | 0.140 |
Why?
|
Diet, Mediterranean | 2 | 2022 | 748 | 0.140 |
Why?
|
Feasibility Studies | 10 | 2023 | 5323 | 0.140 |
Why?
|
Radiographic Image Enhancement | 2 | 2013 | 877 | 0.140 |
Why?
|
Fistula | 1 | 2018 | 213 | 0.130 |
Why?
|
Rhabdomyolysis | 1 | 2018 | 150 | 0.130 |
Why?
|
Minority Groups | 1 | 2024 | 1216 | 0.130 |
Why?
|
Models, Economic | 3 | 2017 | 721 | 0.130 |
Why?
|
Bibliometrics | 1 | 2020 | 355 | 0.130 |
Why?
|
Multifactorial Inheritance | 1 | 2024 | 1423 | 0.130 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2020 | 9080 | 0.130 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2023 | 1243 | 0.130 |
Why?
|
Endocarditis, Bacterial | 1 | 2020 | 436 | 0.130 |
Why?
|
Overweight | 3 | 2022 | 2448 | 0.130 |
Why?
|
Heart Function Tests | 1 | 2016 | 317 | 0.130 |
Why?
|
Edema | 1 | 2019 | 766 | 0.130 |
Why?
|
Specialization | 1 | 2020 | 780 | 0.120 |
Why?
|
Health Services | 2 | 2020 | 755 | 0.120 |
Why?
|
Preoperative Period | 1 | 2017 | 565 | 0.120 |
Why?
|
Cross-Sectional Studies | 14 | 2022 | 26395 | 0.120 |
Why?
|
Radionuclide Imaging | 3 | 2018 | 1998 | 0.120 |
Why?
|
Thoracic Injuries | 1 | 2018 | 288 | 0.120 |
Why?
|
Tissue Survival | 2 | 2020 | 120 | 0.120 |
Why?
|
Double-Blind Method | 6 | 2017 | 12467 | 0.120 |
Why?
|
Incidental Findings | 1 | 2020 | 697 | 0.120 |
Why?
|
Insulin Resistance | 3 | 2022 | 3982 | 0.120 |
Why?
|
Radiography | 3 | 2014 | 6991 | 0.120 |
Why?
|
Debridement | 1 | 2017 | 494 | 0.120 |
Why?
|
Radiology Information Systems | 1 | 2019 | 533 | 0.120 |
Why?
|
Cost of Illness | 3 | 2020 | 1960 | 0.120 |
Why?
|
Prosthesis-Related Infections | 1 | 2020 | 497 | 0.120 |
Why?
|
Chronic Disease | 5 | 2024 | 9384 | 0.120 |
Why?
|
Hospitalization | 8 | 2023 | 10847 | 0.110 |
Why?
|
Radiation Protection | 3 | 2015 | 428 | 0.110 |
Why?
|
Takayasu Arteritis | 1 | 2015 | 106 | 0.110 |
Why?
|
Necrosis | 3 | 2020 | 1620 | 0.110 |
Why?
|
Reimbursement Mechanisms | 1 | 2019 | 677 | 0.110 |
Why?
|
Adolescent | 17 | 2024 | 89244 | 0.110 |
Why?
|
Computer Simulation | 3 | 2017 | 6291 | 0.110 |
Why?
|
Pulmonary Embolism | 2 | 2018 | 2600 | 0.110 |
Why?
|
Protestantism | 2 | 2023 | 9 | 0.110 |
Why?
|
Diastole | 2 | 2017 | 785 | 0.110 |
Why?
|
Cerebrovascular Disorders | 1 | 2020 | 1486 | 0.110 |
Why?
|
Equipment Failure Analysis | 1 | 2015 | 848 | 0.110 |
Why?
|
Cardiac Volume | 1 | 2013 | 197 | 0.110 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2020 | 1360 | 0.110 |
Why?
|
Aging | 3 | 2019 | 8745 | 0.100 |
Why?
|
Respiratory Rate | 1 | 2014 | 180 | 0.100 |
Why?
|
Ischemic Attack, Transient | 1 | 2018 | 877 | 0.100 |
Why?
|
Atrial Function, Left | 1 | 2014 | 188 | 0.100 |
Why?
|
Influenza, Human | 2 | 2021 | 1542 | 0.100 |
Why?
|
Wolff-Parkinson-White Syndrome | 1 | 2013 | 117 | 0.100 |
Why?
|
Disease-Free Survival | 5 | 2019 | 6856 | 0.100 |
Why?
|
Disease Management | 3 | 2024 | 2537 | 0.100 |
Why?
|
Rest | 2 | 2015 | 951 | 0.100 |
Why?
|
Fluorobenzenes | 2 | 2011 | 179 | 0.100 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2018 | 843 | 0.100 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2018 | 644 | 0.100 |
Why?
|
Hot Temperature | 1 | 2019 | 1441 | 0.100 |
Why?
|
Health Behavior | 2 | 2022 | 2649 | 0.100 |
Why?
|
Adenosine A2 Receptor Agonists | 1 | 2012 | 31 | 0.100 |
Why?
|
Statistics, Nonparametric | 2 | 2016 | 2862 | 0.100 |
Why?
|
Propensity Score | 1 | 2020 | 1968 | 0.100 |
Why?
|
Tomography, Emission-Computed | 1 | 2015 | 1126 | 0.100 |
Why?
|
Bioprosthesis | 1 | 2017 | 593 | 0.100 |
Why?
|
Antifungal Agents | 1 | 2017 | 761 | 0.100 |
Why?
|
Terminology as Topic | 1 | 2019 | 1541 | 0.100 |
Why?
|
Electronic Health Records | 2 | 2021 | 4879 | 0.100 |
Why?
|
Models, Anatomic | 1 | 2015 | 683 | 0.100 |
Why?
|
Radiosurgery | 1 | 2021 | 1346 | 0.100 |
Why?
|
Residence Characteristics | 1 | 2022 | 2121 | 0.100 |
Why?
|
Mammaplasty | 1 | 2022 | 1263 | 0.100 |
Why?
|
Device Removal | 1 | 2017 | 643 | 0.100 |
Why?
|
Patient Readmission | 2 | 2018 | 3313 | 0.100 |
Why?
|
Pacemaker, Artificial | 1 | 2017 | 828 | 0.100 |
Why?
|
Prosthesis Design | 2 | 2015 | 2126 | 0.090 |
Why?
|
Anticoagulants | 2 | 2018 | 4850 | 0.090 |
Why?
|
Vasodilation | 2 | 2012 | 967 | 0.090 |
Why?
|
Liver Diseases | 1 | 2020 | 1305 | 0.090 |
Why?
|
Regional Blood Flow | 1 | 2014 | 1500 | 0.090 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2012 | 877 | 0.090 |
Why?
|
Phenotype | 3 | 2024 | 16731 | 0.090 |
Why?
|
Quality of Life | 3 | 2022 | 13510 | 0.090 |
Why?
|
Advisory Committees | 1 | 2015 | 797 | 0.090 |
Why?
|
Tomography, Optical Coherence | 1 | 2024 | 2957 | 0.090 |
Why?
|
Athletes | 1 | 2018 | 1162 | 0.090 |
Why?
|
Adrenal Cortex Hormones | 2 | 2024 | 1892 | 0.090 |
Why?
|
Risk | 4 | 2020 | 9621 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 2 | 2022 | 3235 | 0.090 |
Why?
|
Inpatients | 1 | 2022 | 2569 | 0.090 |
Why?
|
Risk Management | 1 | 2014 | 558 | 0.090 |
Why?
|
Coronary Occlusion | 1 | 2013 | 306 | 0.090 |
Why?
|
Breast Neoplasms | 3 | 2022 | 21188 | 0.090 |
Why?
|
Case-Control Studies | 5 | 2021 | 22296 | 0.090 |
Why?
|
Watchful Waiting | 1 | 2014 | 498 | 0.090 |
Why?
|
Probability | 2 | 2014 | 2483 | 0.090 |
Why?
|
Diabetes Complications | 1 | 2017 | 1320 | 0.080 |
Why?
|
Warfarin | 1 | 2018 | 1493 | 0.080 |
Why?
|
Hematopoiesis | 1 | 2019 | 2059 | 0.080 |
Why?
|
Sex Distribution | 4 | 2019 | 2280 | 0.080 |
Why?
|
Anticholesteremic Agents | 1 | 2017 | 972 | 0.080 |
Why?
|
Antihypertensive Agents | 2 | 2010 | 2027 | 0.080 |
Why?
|
Critical Pathways | 1 | 2013 | 476 | 0.080 |
Why?
|
Injections, Intra-Arterial | 1 | 2009 | 181 | 0.080 |
Why?
|
Health Care Surveys | 4 | 2018 | 2437 | 0.080 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2010 | 97 | 0.080 |
Why?
|
Lymphoproliferative Disorders | 1 | 2013 | 529 | 0.080 |
Why?
|
Drug Therapy, Combination | 2 | 2017 | 6320 | 0.080 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2023 | 1514 | 0.080 |
Why?
|
Molecular Probe Techniques | 1 | 2010 | 111 | 0.080 |
Why?
|
Intra-Abdominal Fat | 1 | 2014 | 625 | 0.080 |
Why?
|
Health Status Disparities | 2 | 2019 | 1886 | 0.080 |
Why?
|
User-Computer Interface | 1 | 2015 | 1406 | 0.080 |
Why?
|
Educational Status | 3 | 2023 | 2515 | 0.080 |
Why?
|
Ultrasonography, Doppler | 1 | 2011 | 463 | 0.080 |
Why?
|
Perioperative Care | 1 | 2016 | 1045 | 0.080 |
Why?
|
Periodicals as Topic | 1 | 2020 | 1470 | 0.080 |
Why?
|
Social Class | 1 | 2017 | 2009 | 0.080 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2021 | 2171 | 0.080 |
Why?
|
Pressoreceptors | 1 | 2008 | 99 | 0.080 |
Why?
|
Kidney Transplantation | 1 | 2024 | 4265 | 0.080 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2013 | 580 | 0.080 |
Why?
|
Heart Septum | 1 | 2009 | 304 | 0.080 |
Why?
|
Particulate Matter | 1 | 2020 | 2615 | 0.080 |
Why?
|
Quality of Health Care | 3 | 2018 | 4339 | 0.080 |
Why?
|
Unnecessary Procedures | 1 | 2012 | 419 | 0.080 |
Why?
|
Guidelines as Topic | 1 | 2015 | 1399 | 0.080 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3238 | 0.070 |
Why?
|
Hip Fractures | 1 | 2016 | 997 | 0.070 |
Why?
|
Mitral Valve Prolapse | 1 | 2010 | 213 | 0.070 |
Why?
|
Education, Medical | 1 | 2020 | 1742 | 0.070 |
Why?
|
Fontan Procedure | 1 | 2014 | 805 | 0.070 |
Why?
|
Heart Block | 1 | 2009 | 390 | 0.070 |
Why?
|
Radiography, Thoracic | 1 | 2014 | 1321 | 0.070 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2017 | 1189 | 0.070 |
Why?
|
Animals | 7 | 2024 | 169335 | 0.070 |
Why?
|
Rupture, Spontaneous | 2 | 2020 | 365 | 0.070 |
Why?
|
Cardiomegaly | 1 | 2010 | 591 | 0.070 |
Why?
|
Workplace | 1 | 2014 | 873 | 0.070 |
Why?
|
Substance-Related Disorders | 2 | 2021 | 4423 | 0.070 |
Why?
|
Hospitals, General | 1 | 2012 | 810 | 0.070 |
Why?
|
Neoplasms | 4 | 2022 | 22389 | 0.070 |
Why?
|
Blood Volume | 1 | 2008 | 546 | 0.070 |
Why?
|
Patient Compliance | 1 | 2017 | 2701 | 0.070 |
Why?
|
Venous Thrombosis | 1 | 2016 | 1321 | 0.070 |
Why?
|
Adiposity | 2 | 2014 | 1895 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 1 | 2019 | 3408 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2784 | 0.070 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2016 | 1399 | 0.070 |
Why?
|
Hospital Charges | 2 | 2019 | 351 | 0.070 |
Why?
|
Air Pollution | 1 | 2020 | 2372 | 0.070 |
Why?
|
Syndrome | 1 | 2012 | 3274 | 0.070 |
Why?
|
Patient Satisfaction | 1 | 2019 | 3492 | 0.070 |
Why?
|
Air Pollutants | 1 | 2020 | 2915 | 0.070 |
Why?
|
Arterial Occlusive Diseases | 1 | 2010 | 746 | 0.070 |
Why?
|
Brain Ischemia | 1 | 2019 | 3008 | 0.060 |
Why?
|
Renal Dialysis | 1 | 2015 | 1789 | 0.060 |
Why?
|
Stress, Physiological | 1 | 2013 | 1408 | 0.060 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 428 | 0.060 |
Why?
|
Poverty | 1 | 2017 | 2720 | 0.060 |
Why?
|
Midwestern United States | 1 | 2005 | 70 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2012 | 2360 | 0.060 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5375 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4207 | 0.060 |
Why?
|
Sympathetic Nervous System | 1 | 2008 | 521 | 0.060 |
Why?
|
Sleep Apnea Syndromes | 1 | 2014 | 984 | 0.060 |
Why?
|
Radiometry | 1 | 2011 | 817 | 0.060 |
Why?
|
Research Design | 2 | 2020 | 6214 | 0.060 |
Why?
|
Health Services Accessibility | 2 | 2020 | 5522 | 0.060 |
Why?
|
Health Policy | 1 | 2017 | 2700 | 0.060 |
Why?
|
Body Surface Area | 1 | 2005 | 206 | 0.060 |
Why?
|
Pneumonia | 1 | 2016 | 2164 | 0.060 |
Why?
|
Extracellular Matrix | 1 | 2012 | 1739 | 0.060 |
Why?
|
Transplantation, Homologous | 1 | 2013 | 4835 | 0.060 |
Why?
|
Sulfonamides | 2 | 2011 | 1981 | 0.060 |
Why?
|
Arteries | 2 | 2023 | 1126 | 0.060 |
Why?
|
Population Surveillance | 1 | 2014 | 2597 | 0.060 |
Why?
|
Heart-Assist Devices | 1 | 2014 | 1292 | 0.050 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3269 | 0.050 |
Why?
|
Body Weight | 2 | 2013 | 4628 | 0.050 |
Why?
|
Software | 2 | 2015 | 4479 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3928 | 0.050 |
Why?
|
Shock | 1 | 2005 | 316 | 0.050 |
Why?
|
Communication | 1 | 2017 | 3908 | 0.050 |
Why?
|
Blood Glucose | 4 | 2018 | 6435 | 0.050 |
Why?
|
Pyrimidines | 2 | 2011 | 3048 | 0.050 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2022 | 184 | 0.050 |
Why?
|
Iopamidol | 2 | 2014 | 187 | 0.050 |
Why?
|
Dementia | 1 | 2016 | 2741 | 0.050 |
Why?
|
Child, Preschool | 2 | 2022 | 42683 | 0.050 |
Why?
|
Age Distribution | 2 | 2019 | 2875 | 0.050 |
Why?
|
Health Promotion | 1 | 2014 | 2210 | 0.050 |
Why?
|
Nutrition Surveys | 2 | 2020 | 1738 | 0.050 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 3253 | 0.050 |
Why?
|
Internet | 1 | 2014 | 3112 | 0.050 |
Why?
|
Databases, Factual | 3 | 2019 | 8094 | 0.050 |
Why?
|
Food Analysis | 1 | 2021 | 103 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2014 | 15889 | 0.050 |
Why?
|
Leadership | 2 | 2020 | 1396 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2013 | 10765 | 0.040 |
Why?
|
Diphosphates | 1 | 2020 | 89 | 0.040 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2013 | 1899 | 0.040 |
Why?
|
Denmark | 1 | 2023 | 776 | 0.040 |
Why?
|
Pericarditis | 1 | 2022 | 136 | 0.040 |
Why?
|
Greenland | 1 | 2019 | 5 | 0.040 |
Why?
|
Radiation Injuries | 2 | 2022 | 1203 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2010 | 2339 | 0.040 |
Why?
|
Cost Allocation | 1 | 2019 | 48 | 0.040 |
Why?
|
Maryland | 1 | 2020 | 279 | 0.040 |
Why?
|
History, 16th Century | 1 | 2019 | 70 | 0.040 |
Why?
|
Food Service, Hospital | 1 | 2019 | 18 | 0.040 |
Why?
|
Spironolactone | 1 | 2023 | 415 | 0.040 |
Why?
|
Search Engine | 1 | 2020 | 142 | 0.040 |
Why?
|
Acute Disease | 3 | 2015 | 7245 | 0.040 |
Why?
|
Ultrasonography | 2 | 2013 | 6002 | 0.040 |
Why?
|
Breast Implantation | 1 | 2022 | 225 | 0.040 |
Why?
|
Calcium, Dietary | 1 | 2022 | 533 | 0.040 |
Why?
|
Mediastinum | 1 | 2020 | 272 | 0.040 |
Why?
|
Models, Biological | 1 | 2015 | 9499 | 0.040 |
Why?
|
Review Literature as Topic | 1 | 2020 | 298 | 0.040 |
Why?
|
Aspartate Aminotransferases | 1 | 2020 | 414 | 0.040 |
Why?
|
Prealbumin | 1 | 2020 | 259 | 0.040 |
Why?
|
Carotid Artery, Common | 1 | 2019 | 175 | 0.040 |
Why?
|
Elastic Modulus | 1 | 2019 | 211 | 0.040 |
Why?
|
Tomography | 1 | 2020 | 442 | 0.040 |
Why?
|
Retinal Vessels | 1 | 2024 | 864 | 0.040 |
Why?
|
Pulmonary Medicine | 1 | 2020 | 223 | 0.040 |
Why?
|
Drug Prescriptions | 2 | 2018 | 1673 | 0.040 |
Why?
|
Diet, Vegetarian | 1 | 2019 | 181 | 0.040 |
Why?
|
Adipose Tissue | 1 | 2009 | 3335 | 0.040 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2020 | 582 | 0.040 |
Why?
|
Alanine Transaminase | 1 | 2020 | 606 | 0.040 |
Why?
|
Reference Values | 2 | 2016 | 4940 | 0.040 |
Why?
|
Regression Analysis | 2 | 2019 | 6346 | 0.030 |
Why?
|
Hypercalcemia | 1 | 2020 | 424 | 0.030 |
Why?
|
Organizational Policy | 1 | 2019 | 435 | 0.030 |
Why?
|
Alkaline Phosphatase | 1 | 2020 | 864 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2023 | 1064 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 2013 | 4919 | 0.030 |
Why?
|
Glomerular Filtration Rate | 2 | 2017 | 2228 | 0.030 |
Why?
|
Carotid Artery, Internal | 1 | 2019 | 445 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1757 | 0.030 |
Why?
|
Economics, Hospital | 1 | 2018 | 210 | 0.030 |
Why?
|
Electric Impedance | 1 | 2020 | 795 | 0.030 |
Why?
|
Endosonography | 1 | 2020 | 626 | 0.030 |
Why?
|
Emergency Treatment | 1 | 2019 | 497 | 0.030 |
Why?
|
Bayes Theorem | 2 | 2017 | 2360 | 0.030 |
Why?
|
Expert Testimony | 1 | 2017 | 266 | 0.030 |
Why?
|
Nutrition Policy | 1 | 2019 | 467 | 0.030 |
Why?
|
History, 21st Century | 1 | 2021 | 1575 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1794 | 0.030 |
Why?
|
Mutation | 1 | 2019 | 30266 | 0.030 |
Why?
|
Self Concept | 1 | 2020 | 1046 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2022 | 1281 | 0.030 |
Why?
|
Eye Diseases | 1 | 2020 | 658 | 0.030 |
Why?
|
Creatinine | 1 | 2020 | 1917 | 0.030 |
Why?
|
Software Validation | 1 | 2014 | 59 | 0.030 |
Why?
|
Bronchoscopy | 1 | 2020 | 914 | 0.030 |
Why?
|
Automation, Laboratory | 1 | 2014 | 102 | 0.030 |
Why?
|
Reoperation | 1 | 2024 | 4342 | 0.030 |
Why?
|
Nausea | 1 | 2016 | 682 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2020 | 2921 | 0.030 |
Why?
|
PubMed | 1 | 2014 | 130 | 0.030 |
Why?
|
Radioisotopes | 1 | 2015 | 517 | 0.030 |
Why?
|
Pilot Projects | 2 | 2019 | 8748 | 0.030 |
Why?
|
Whole Body Imaging | 1 | 2015 | 284 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2012 | 6236 | 0.030 |
Why?
|
Infection Control | 1 | 2020 | 985 | 0.030 |
Why?
|
Republic of Korea | 1 | 2015 | 592 | 0.030 |
Why?
|
Molecular Targeted Therapy | 1 | 2024 | 2830 | 0.030 |
Why?
|
Discriminant Analysis | 1 | 2013 | 222 | 0.030 |
Why?
|
Models, Educational | 1 | 2015 | 375 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2018 | 936 | 0.030 |
Why?
|
Hemorrhage | 2 | 2015 | 3466 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2022 | 2434 | 0.030 |
Why?
|
Tennessee | 1 | 2012 | 123 | 0.030 |
Why?
|
Tobacco Smoke Pollution | 1 | 2018 | 828 | 0.020 |
Why?
|
Quality Control | 1 | 2015 | 836 | 0.020 |
Why?
|
Lysosomal Storage Diseases | 1 | 2012 | 81 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2017 | 1262 | 0.020 |
Why?
|
Exercise Tolerance | 1 | 2017 | 846 | 0.020 |
Why?
|
Extracellular Space | 1 | 2013 | 565 | 0.020 |
Why?
|
Calcification, Physiologic | 1 | 2012 | 171 | 0.020 |
Why?
|
Ischemia | 1 | 2020 | 1900 | 0.020 |
Why?
|
Ohio | 1 | 2012 | 321 | 0.020 |
Why?
|
Drugs, Generic | 1 | 2017 | 455 | 0.020 |
Why?
|
Sample Size | 1 | 2015 | 848 | 0.020 |
Why?
|
Organ Size | 1 | 2016 | 2268 | 0.020 |
Why?
|
Tunica Media | 1 | 2011 | 111 | 0.020 |
Why?
|
Europe | 1 | 2018 | 3441 | 0.020 |
Why?
|
Tachycardia | 2 | 1983 | 599 | 0.020 |
Why?
|
Documentation | 1 | 2017 | 917 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2017 | 2108 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2017 | 1741 | 0.020 |
Why?
|
Triiodobenzoic Acids | 1 | 2010 | 123 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2012 | 1002 | 0.020 |
Why?
|
Echocardiography, Doppler | 1 | 2013 | 898 | 0.020 |
Why?
|
Pericardium | 1 | 2014 | 679 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2015 | 2932 | 0.020 |
Why?
|
Telemetry | 1 | 2010 | 200 | 0.020 |
Why?
|
Hypertension, Pulmonary | 1 | 2020 | 1601 | 0.020 |
Why?
|
Tunica Intima | 1 | 2011 | 459 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2014 | 1680 | 0.020 |
Why?
|
Causality | 1 | 2015 | 1256 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2020 | 3473 | 0.020 |
Why?
|
Educational Measurement | 1 | 2015 | 1260 | 0.020 |
Why?
|
California | 1 | 2012 | 1443 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2024 | 18068 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2011 | 1376 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2020 | 3110 | 0.020 |
Why?
|
Teaching | 1 | 2015 | 1171 | 0.020 |
Why?
|
Waist Circumference | 1 | 2011 | 935 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2016 | 1751 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2013 | 1820 | 0.020 |
Why?
|
Death | 1 | 2011 | 683 | 0.020 |
Why?
|
Carotid Arteries | 1 | 2011 | 943 | 0.020 |
Why?
|
Vitamin D | 1 | 2020 | 3311 | 0.020 |
Why?
|
Ventricular Function, Right | 1 | 2010 | 628 | 0.020 |
Why?
|
Triglycerides | 1 | 2013 | 2464 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2018 | 4045 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2020 | 4544 | 0.020 |
Why?
|
Peripheral Arterial Disease | 1 | 2016 | 1304 | 0.010 |
Why?
|
Fibrinolytic Agents | 1 | 2014 | 2080 | 0.010 |
Why?
|
Endomyocardial Fibrosis | 1 | 1983 | 41 | 0.010 |
Why?
|
Cardiac Complexes, Premature | 1 | 1983 | 63 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2016 | 5151 | 0.010 |
Why?
|
Motor Activity | 1 | 2013 | 2713 | 0.010 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2010 | 1724 | 0.010 |
Why?
|
Fever | 1 | 2010 | 1619 | 0.010 |
Why?
|
Mental Health | 1 | 2017 | 3275 | 0.010 |
Why?
|
Dyspnea | 1 | 2010 | 1352 | 0.010 |
Why?
|
Signal Transduction | 1 | 2024 | 23653 | 0.010 |
Why?
|
Ventricular Fibrillation | 1 | 1983 | 537 | 0.010 |
Why?
|
Cardiac Pacing, Artificial | 1 | 1983 | 881 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2013 | 22379 | 0.010 |
Why?
|
Internship and Residency | 1 | 2015 | 5956 | 0.010 |
Why?
|
Child | 1 | 2019 | 80960 | 0.010 |
Why?
|
Mice | 1 | 2013 | 82072 | 0.000 |
Why?
|
Sick Sinus Syndrome | 1 | 1983 | 51 | 0.000 |
Why?
|
Azathioprine | 1 | 1984 | 354 | 0.000 |
Why?
|
Electrodes | 1 | 1983 | 617 | 0.000 |
Why?
|
Prednisone | 1 | 1984 | 1567 | 0.000 |
Why?
|
Electric Stimulation | 1 | 1983 | 1742 | 0.000 |
Why?
|
Preoperative Care | 1 | 1983 | 2258 | 0.000 |
Why?
|